Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system.
Through the years, Cenova has built a reputation among its current and potential portfolio companies, industry leaders, multinational companies and its peers, as a leading fund for life science investments in China.
Currently, Cenova has five funds under management invested in over 50 companies with a proven track record across three funds. Its investors include large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 53 Gaoyou Road, Xuhui District, Shanghai,china
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.cenovaventures.com
- Keywords
- digital health.
- HQ
- Shanghai
Cenova Capital Questions
Cenova Capital's website is http://www.cenovaventures.com
Cenova Capital's LinkedIn profile is https://cn.linkedin.com/company/cenova-capital
Cenova Capital has
13 employees.
View email and phone details for 13
employees at Cenova Capital.
Cenova Capital's industry is
Venture Capital and Private Equity Principals
Cenova Capital's top competitors are
Sinovation Ventures (创新工场),
Ally Bridge Group,
Vivace Therapeutics, Inc.,
Youshan Capital 优山资本,
Co-Win Ventures 凯风创投,
Hillhouse Investment,
Cbc Group,
Sichuan Venture Capital,
Eight Roads,
Cherubic Ventures.
Cenova Capital's categories are Venture Capital and Private Equity Principals
Cenova Capital's founding year is 2010
